Richard K. Chaudhary, MS

Kodra TAVR Table 1

Original Contribution

Short- and Mid-Term Outcomes of Complex and High-Risk Versus Standard Percutaneous Coronary Interventions in Patients Undergoing Transcatheter Aortic Valve Replacement

02/01/2023

Denny Wang , BS ;

Hamfreth Rahming , MD;

Richard K. Chaudhary , MS;

Shangyi Liu , MS;

Ahmad Mustafa , MD;

Bruce Rutkin , MD;

Chad Kliger , MS, MD;

Gregory Maniatis , MD;

Luigi Pirelli , MD;

Robert Kalimi , MD;

Sean R. Wilson , MD;

Varinder Singh , MD;

Pey-Jen Yu , MD;

Michael S. Kim , MD, FACC, FSCAI;

Perwaiz Meraj , MD, MPH;

Rajiv Jauhar , MD, FACC, FSCAI;

Ruben Kandov , MD;

Puneet Gandotra , MD;

Arber Kodra , MD;

S. Jacob Scheinerman , MD;

Craig Basman , MD;

The prevalence of coronary artery disease (CAD) in patients undergoing TAVR varies and is associated with increased morbidity and mortality. We evaluated the outcomes of complex and high-risk percutaneous coronary interventions (CHIP-PCIs)...

The prevalence of coronary artery disease (CAD) in patients undergoing TAVR varies and is associated with increased morbidity and mortality. We evaluated the outcomes of complex and high-risk percutaneous coronary interventions (CHIP-PCIs)...

The prevalence of coronary...

02/01/2023

Journal of Invasive Cardiology

CIO 2022-23 Radioembolization as a Locoregional Treatment of Hepatic Metastasis of Melanoma

Purpose: To evaluate the effectiveness, safety, and predictors of outcome of patients treated with yttrium-90 (90Y) radioembolization for hepatic involvement of metastatic melanoma. ...

Richard K. Chaudhary , MS;

10/18/2022

CIO 2022-21 Outcome of Microwave Ablation of Stage 1a Renal Cell Carcinoma in a Community-Based Practice

Purpose: Thermal ablation is recommended as an option for category T1a renal cell carcinoma (RCC) when there are major comorbidities and an increased surgical risk for invasive nephrectom...

Richard K. Chaudhary , MS;

10/18/2022

Featured CME Course

Targeted Therapies for the Management of Chronic Lymphocytic Leukemia: Evaluating the Evidence to Optimize Patient Care and Outcomes

Upcoming Events

February 2 ⁠–⁠ February 5

February 7 ⁠–⁠ February 9

February 27 ⁠–⁠ March 1

DCLF

March 17 ⁠–⁠ March 19

March 22 ⁠–⁠ March 23

NP Institute

March 27 ⁠–⁠ March 30

March 31 ⁠–⁠ April 2

April 21 ⁠–⁠ April 24

April 30 ⁠–⁠ May 4

WoundCon

May 1 ⁠–⁠ May 3

See Full Calendar